ABILIFY MAINTENA 720 MG SUSPENSION INYECTABLE DE LIBERACIÓN PROLONGADA EN JERINGA PRECARGADA

( ARTG ) - ABILIFY is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. - Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate; - Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.